However, both VEGFR2 and VEGFR3 are expressed on normal liver and tumor endothelial cells, indicating that VEGF-C may potentially be a relevant proangiogenic factor in HCC [21,22]. The gene discussed is VEGFC; the disease is hepatocellular carcinoma.